Buyers keen on shares from the Medical Companies sector have in all probability already heard of Progyny (PGNY) and HealthEquity (HQY). However which of those two shares is extra enticing to worth traders? We’ll have to take a better look to search out out.
There are many methods for locating worth shares, however we’ve got discovered that pairing a powerful Zacks Rank with a formidable grade within the Worth class of our Fashion Scores system produces the most effective returns. The Zacks Rank is a confirmed technique that targets firms with optimistic earnings estimate revision tendencies, whereas our Fashion Scores work to grade firms primarily based on particular traits.
Proper now, Progyny is sporting a Zacks Rank of #2 (Purchase), whereas HealthEquity has a Zacks Rank of #3 (Maintain). Because of this PGNY’s earnings estimate revision exercise has been extra spectacular, so traders ought to really feel snug with its bettering analyst outlook. However this is only one piece of the puzzle for worth traders.
Worth traders additionally have a tendency to take a look at numerous conventional, tried-and-true figures to assist them discover shares that they imagine are undervalued at their present share worth ranges.
Our Worth class grades shares primarily based on numerous key metrics, together with the tried-and-true P/E ratio, the P/S ratio, earnings yield, and money stream per share, in addition to a wide range of different fundamentals that worth traders continuously use.
PGNY presently has a ahead P/E ratio of 13.82, whereas HQY has a ahead P/E of 25.75. We additionally notice that PGNY has a PEG ratio of 0.83. This well-liked metric is much like the widely-known P/E ratio, with the distinction being that the PEG ratio additionally takes under consideration the corporate’s anticipated earnings progress charge. HQY presently has a PEG ratio of 1.19.
One other notable valuation metric for PGNY is its P/B ratio of three.75. Buyers use the P/B ratio to take a look at a inventory’s market worth versus its e book worth, which is outlined as complete belongings minus complete liabilities. By comparability, HQY has a P/B of three.99.
These metrics, and a number of other others, assist PGNY earn a Worth grade of B, whereas HQY has been given a Worth grade of D.
PGNY has seen stronger estimate revision exercise and sports activities extra enticing valuation metrics than HQY, so it looks as if worth traders will conclude that PGNY is the superior possibility proper now.
Zacks’ Analysis Chief Names “Inventory Most More likely to Double”
Our workforce of consultants has simply launched the 5 shares with the best likelihood of gaining +100% or extra within the coming months. Of these 5, Director of Analysis Sheraz Mian highlights the one inventory set to climb highest.
This prime decide is a little-known satellite-based communications agency. House is projected to grow to be a trillion greenback business, and this firm’s buyer base is rising quick. Analysts have forecasted a significant income breakout in 2025. In fact, all our elite picks aren’t winners however this one might far surpass earlier Zacks’ Shares Set to Double like Hims & Hers Well being, which shot up +209%.
Free: See Our Prime Inventory And 4 Runners Up
Progyny, Inc. (PGNY) : Free Inventory Evaluation Report
HealthEquity, Inc. (HQY) : Free Inventory Evaluation Report
This text initially revealed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
